|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 53.51 CNY | -16.60% |
|
-15.60% | -10.32% |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
: Breakdown by Business Segment
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
Preparations | - | 30Cr | 23Cr | 19Cr | 5.54Cr | |||
Active Pharmaceutical Ingredient (api) | - | - | - | 1.03Cr | 4.97Cr | |||
Intermediate | - | 10Cr | 9.96Cr | 3.8Cr | 3.9Cr | |||
Others | 6.43Cr | - | - | 55.1L | 1.01Cr | |||
Gross Profit | - | - | - | - | - | |||
Sodium Acetate Ringer's Injection | 47Cr | - | - | - | - | |||
Gross Profit | - | - | - | - | - |
Geographical Revenue Distribution History
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
China | 53Cr | 40Cr | 33Cr | 24Cr | 15Cr | |||
Total Assets | 85Cr | 90Cr | 107.23Cr | 153.5Cr | 128.32Cr | |||
Interest Expense | -11.79L | -13.6L | -31.13L | -79L | -1.79Cr | |||
Income Tax Expense | 74.18L | 24.41L | 51.57L | -7L | 10.44L | |||
D&A | 1.48Cr | 1.57Cr | 1.87Cr | 2.93Cr | 5.2Cr | |||
CAPEX | -53.46L | -3.27Cr | -2.37Cr | -4.09Cr | -10Cr | |||
Net Income | 6.85Cr | 2.05Cr | 1.89Cr | -6.27Cr | -10Cr | |||
EBT | 7.33Cr | 2.1Cr | 2.22Cr | -8.58Cr | -13Cr | |||
Operating Income | 7.34Cr | 2.13Cr | 2.22Cr | -8.58Cr | -13Cr |
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
